49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03656627 (ClinicalTrials.gov)	June 27, 2019	31/8/2018	Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease	Safety, Activity, and Pharmacology of Nivolumabin Patients With Advanced Non-Small Cell Lung Cancer ...	Autoimmune Diseases;Non-small Cell Lung Cancer;Rheumatoid Arthritis;Psoriasis;Giant Cell Arteritis;P ...	Drug: Nivolumab	Alliance Foundation Trials, LLC.	Bristol-Myers Squibb	Terminated	18 Years	N/A	All	7	Phase 1	United States
2	NCT03816345 (ClinicalTrials.gov)	April 4, 2019	24/1/2019	Nivolumabin Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Ca ...	A Phase Ib Study of Nivolumabin Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NI ...	Advanced Malignant Solid Neoplasm;Autoimmune Disease;Crohn Disease;Dermatomyositis;Hematopoietic and ...	Procedure: Biospecimen Collection;Biological: Nivolumab	National Cancer Institute (NCI)	NULL	Recruiting	18 Years	N/A	All	300	Phase 1	United States;Canada

First Previous1Next Last